24th Romanian National Congress

Oncology Meeting Resources

23 Oct - 25 Oct, Sinaia, Romania

On this page, PDF versions of presentations given at the 24th Romanian National Congress are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Search Meeting Resources by Keyword

Useful link

Presenter Presentation title Session title
Ovidiu Balacescu New biomarker targets: circulating tumor cells, circulating DNA, miRNAs Course on Advances in molecular targeted therapy - part 1
Lucian Miron Is there still a role for cytotoxic chemotherapy in NSCLC in the era of personalized treatments ? Course on Advances in molecular targeted therapy - part 1
Gabriel Kacso Post-ASCO/ post-ESMO - update in solid tumors: Genitourinary tumors Course on Advances in molecular targeted therapy - part 2
Calin Cainap Role of nutrition and supplements in cancer prevention and treatment Early Prevention and Detection/ Epidemiology
Ovidiu Balacescu Circulating Tumor Biomarkers Scientific symposium: Molecular diagnosis and testing in oncology
Thomas Brodowicz New developments in the systemic treatment of colorectal cancer: Right patients, right time and right therapy Treatment of Digestive Tumors
Lucian Miron Role of adjuvant chemotherapy in stage II CRC Treatment of Digestive Tumors
Calin Cainap Update in the systemic treatment of gastric cancer Treatment of Digestive Tumors
Gabriel Kacso Modern radiotherapy techniques in urogenital tumors Actualities and controversies in radiotherapy: roundtable
Gabriel Kacso Changing paradigms in metastatic prostate cancer Genito-urinary cancers session
Jean Pierre Armand Phase 1, a critical moment for discovery of a new drugs Clinical trials
Tudor E. Ciuleanu Introducing personalized therapy in Romania Clinical trials
Mircea Dediu Second line treatment in advanced NSCLC Lung cancer session
Lucian Miron Small cell lung cancer – is there something new? Lung cancer session
Mircea Dediu Is there still a role for anthracyclines in the adjuvant treatment of breast cancer? Breast cancer session 2